Arecor Therapeutics plc reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was GBP 1.67 million compared to GBP 0.693 million a year ago. Revenue was GBP 2.28 million compared to GBP 1.12 million a year ago.
Net loss was GBP 4.53 million compared to GBP 4.37 million a year ago. Basic loss per share from continuing operations was GBP 0.15 compared to GBP 0.16 a year ago.